Illumina Inc (ILMN)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $29.94B
Last updated: Nov 17, 2026 at 4:30 PM ET
Illumina Inc (ILMN) Statistics
Illumina (ILMN) has a market cap of $29.94B and an enterprise value of $30.44B. Its trailing P/E of 38.6x is below its 10-year median of 56.7x. Its return on invested capital of 19.12% compares with a 8.20% median across 11 similar companies.
Total Valuation
Enterprise value is 1.67% above the market cap, as debt exceeds cash.
| Market Cap | $29.94B |
|---|---|
| Enterprise Value | $30.44B |
| Latest price (Nov 17, 2026) | $202.61 |
Key Dates
The next earnings report is expected on Feb 3, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 3, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 29, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 6.7x and 9.7x. Its year-end P/E ranged from 27.0x to 160.0x from 2016 to 2025.
| P/E Ratio | 38.6x |
|---|---|
| Forward P/E | 36.6x |
| P/S Ratio | 6.7x |
| Forward P/S | 6.5x |
| P/B Ratio | 9.7x |
| P/TBV Ratio | 20.8x |
| P/FCF Ratio | 28.9x |
| P/OCF Ratio | 24.3x |
| PEG Ratio | 2.9 |
Enterprise Valuation
Counting debt and cash, the company is valued at 22.3x EBITDA and 29.4x free cash flow.
| EV / Earnings | 34.0x |
|---|---|
| EV / Sales | 6.7x |
| EV / EBITDA | 22.3x |
| EV / EBIT | 27.3x |
| EV / FCF | 29.4x |
Price Statistics
The stock is up 67.90% over 52 weeks and trades 18.45% below its 50-day average.
| Beta (1Y) | 1.12 |
|---|---|
| 52-Week Change | +67.90% |
| 1-Month Change | -22.86% |
| 3-Month Change | -1.17% |
| 6-Month Change | +43.01% |
| 5-Year Change | -43.14% |
| 10-Year Change | +73.34% |
| Total Return (1Y) | +67.90% |
| Total Return (3Y CAGR) | +30.21% |
| Total Return (5Y CAGR) | -11.15% |
| Return vs SPY (1Y) | +54.56% |
| Max Drawdown (1Y) | -32.58% |
| Max Drawdown (3Y) | -54.69% |
| Sharpe Ratio (1Y) | 1.03 |
| Correlation with SPY (1Y) | 0.31 |
| 50-Day Average | $248.45 |
| 200-Day Average | $180.09 |
| 52-Week Range | $112.65 to $309.35 |
| RSI (14 Days) | 35.0 |
| Average Volume (20 Days) | 2.21M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.63x current liabilities, and total debt is 0.57x shareholder equity.
| Current Ratio | 2.63x |
|---|---|
| Quick Ratio | 2.05x |
| Debt / Equity | 0.57x |
| Debt / EBITDA | 1.28x |
| Debt / FCF | 1.69x |
| Interest Coverage | 11.39x |
Returns and Efficiency
Return on invested capital is 19.12% over the last 12 months, against a 5-year average of -12.33%.
| Return on Equity (ROE) | 28.46% |
|---|---|
| Return on Assets (ROA) | 13.14% |
| Return on Invested Capital (ROIC) | 19.12% |
| Return on Capital Employed (ROCE) | 19.73% |
| ROE (5Y Average) | -20.03% |
| ROA (5Y Average) | -9.81% |
| ROIC (5Y Average) | -12.33% |
| Asset Turnover | 0.70x |
| Inventory Turnover | 2.25x |
| Receivables Turnover | 6.04x |
| Cash Conversion Cycle | 164 days |
Taxes
Income tax took 15.49% of pretax income over the last 12 months.
| Income Tax (TTM) | $164.00M |
|---|---|
| Effective Tax Rate | 15.49% |
Scores
ILMN has an Altman Z-Score of 6.58, in the safe zone above 2.99, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 6.58 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 8 of 9 |
| Piotroski Strength | Strong |
Income Statement
Revenue of $4.54B over the last 12 months is up 5.83% from the 12 months before.
| Revenue | $4.54B |
|---|---|
| Revenue Growth (YoY) | +5.83% |
| Gross Profit | $3.08B |
| Operating Income | $961.00M |
| Pretax Income | $1.06B |
| Net Income | $895.00M |
| EBITDA | $1.39B |
| EBIT | $1.12B |
| Reported EPS (TTM) | $5.25 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 46.26% of the $6.81B in total assets.
| Cash and Equivalents | $1.29B |
|---|---|
| Total Debt | $1.79B |
| Net Debt | $500.00M |
| Net Debt Per Share | $3.31 |
| Working Capital | $1.88B |
| Shareholder Equity | $3.15B |
| Book Value Per Share | $20.83 |
| Tangible Book Value | $1.47B |
| Tangible Book Per Share | $9.74 |
| Total Assets | $6.81B |
| Total Liabilities | $3.67B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $173.00M of capital spending, operating cash flow left $1.06B of free cash flow.
| Operating Cash Flow | $1.23B |
|---|---|
| Capital Expenditures | $173.00M |
| Free Cash Flow | $1.06B |
| FCF Per Share | $7.00 |
| Depreciation and Amortization | $277.00M |
| Share Repurchases | $421.00M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 21.18%, against a 5-year average of -23.62%.
| Gross Margin | 67.87% |
|---|---|
| Operating Margin | 21.18% |
| Pretax Margin | 23.34% |
| Net Margin | 19.72% |
| EBITDA Margin | 30.70% |
| EBIT Margin | 24.59% |
| FCF Margin | 23.29% |
| Gross Margin (5Y Average) | 65.39% |
| Operating Margin (5Y Average) | -23.62% |
| Net Margin (5Y Average) | -22.68% |
Growth
Revenue fell 1.78% a year over 3 years, and EPS grew 31.77% a year.
| Revenue Growth (3Y CAGR) | -1.78% |
|---|---|
| Revenue Growth (5Y CAGR) | +6.04% |
| EPS Growth (3Y CAGR) | +31.77% |
| EPS Growth (5Y CAGR) | +1.51% |
| FCF Growth (3Y CAGR) | +106.32% |
| FCF Growth (5Y CAGR) | +0.88% |
| Book Value Per Share Growth (2Y CAGR) | -30.05% |
| Tangible Book Per Share Growth (2Y CAGR) | +164.25% |
Dividends and Yields
ILMN does not pay a dividend. Its free cash flow yield is 3.45%.
| Earnings Yield | 2.59% |
|---|---|
| FCF Yield | 3.45% |
| Buyback Yield | 1.23% |
Stock Splits
The last split was a 2-for-1 forward split on Sep 23, 2008.
| Last Split Date | Sep 23, 2008 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 2:1 |
Peer Position
Against 11 similar companies, ILMN has the 2nd highest P/E and the 3rd highest ROIC.
P/E RatioPeer median 26.6x
P/S RatioPeer median 5.2x
ROICPeer median 8.20%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +7.56%
| P/E Ratio | 38.6x vs 26.6x median |
|---|---|
| P/S Ratio | 6.7x vs 5.2x median |
| ROIC | 19.12% vs 8.20% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +5.83% vs +7.56% median |
Analyst Forecast
Consensus estimates put revenue growth at 6.86% and EPS growth at 12.91% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +6.86% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +12.91% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ILMN
What is ILMN's market cap?
Illumina has a market cap of $29.94B. Its enterprise value, which adds debt and subtracts cash, is $30.44B.
What is ILMN's P/E ratio?
Illumina has a trailing P/E ratio of 38.6x and a forward P/E of 36.6x.
How many shares of ILMN are outstanding?
Illumina has 151.00M shares outstanding. The count is down 1.31% from a year earlier.
Does ILMN pay a dividend?
No. Illumina does not pay a dividend.
How much debt does ILMN have?
Illumina has $1.79B of total debt and $1.29B of cash and equivalents, a net debt position of $500.00M.
ILMN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts